CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $1.51B, above the global median of $548.88M
- PositionGross margin is 25.1%, lower than 95% of its Medical Devices peers (median 58.7%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.82%Below 5Y avg (1.66%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
50.0%Sustainable
Last Ex-Dividend
Jul 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.39BCNY1.10B · vs all stocks (USD)
Trailing P/E
17.40xvs Medical Devices peers
Revenue (TTM)
10.11BCNY1.51B · vs all stocks (USD)
Profit Margin
4.21%vs Medical Devices peers
Beta
0.1130xvs all stocks
52-Week Change
-25.28%vs all stocks
Market Capitalization
7.39BCNY1.10B · vs all stocks (USD)
Enterprise Value
5.69BCNY848.45M · vs all stocks (USD)
Trailing P/E
17.40xvs Medical Devices peers
Forward P/E
7.38xvs Medical Devices peers
Price to Sales (TTM)
0.7311xvs Medical Devices peers
Price to Book (MRQ)
0.9395xvs Medical Devices peers
Enterprise to Revenue
0.5630xvs Medical Devices peers
Enterprise to EBITDA
7.19xvs Medical Devices peers
Gross Margin
25.15%vs Medical Devices peers
Profit Margin
4.21%vs Medical Devices peers
Operating Margin
7.60%vs Medical Devices peers
Return on Assets (TTM)
2.33%vs Medical Devices peers
Return on Equity (TTM)
5.22%vs Medical Devices peers
Revenue (TTM)
10.11BCNY1.51B · vs all stocks (USD)
Revenue per Share (TTM)
16.65CNYUpdated Sep 20, 2026Quarterly Revenue Growth
17.10%vs Medical Devices peers
Gross Profit (TTM)
2.44BCNY363.36M · vs all stocks (USD)
EBITDA (TTM)
916.76MCNY136.80M · vs all stocks (USD)
Net Income (TTM)
425.90MCNY63.55M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-28.40%vs Medical Devices peers
Operating Cash Flow (TTM)
722.62MCNY107.83M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
309.55MCNY46.19M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.82%vs all stocks
5-Year Average Dividend Yield
1.66%vs all stocks
Payout Ratio
50.00%vs Medical Devices peers
Minority Interest (Equity)
323.15MCNYFY2025 · Dec 31, 2025Revenue
9.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.29BCNYFY2025 · Dec 31, 2025Gross Profit
2.45BCNYFY2025 · Dec 31, 2025Operating Income
703.86MCNY105.03M · vs all stocks (USD)
Pre-tax Income
591.12MCNYFY2025 · Dec 31, 2025Income Tax Expense
62.99MCNYFY2025 · Dec 31, 2025Net Income
528.13MCNYFY2025 · Dec 31, 2025EBIT
632.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
990.57MCNYFY2025 · Dec 31, 2025Research & Development
442.03MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
409.54MCNYFY2025 · Dec 31, 2025Other Operating Expenses
74.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
18.44MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
41.41MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.8700CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.8700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
604.98MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
604.98MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
528.13MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.80MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.02BCNYFY2025 · Dec 31, 2025Free Cash Flow
638.61MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.97BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
528.13MCNYFY2025 · Dec 31, 2025Other Non-cash Items
83.26MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
16.37MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
391.35MCNYFY2025 · Dec 31, 2025Capital Expenditures
-380.51MCNYFY2025 · Dec 31, 2025Net Acquisitions
103.56MCNYFY2025 · Dec 31, 2025Purchase of Investments
-23.94MCNYFY2025 · Dec 31, 2025Sale of Investments
118.04MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-182.85MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.19BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.15BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-342.62MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.27MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-309.99MCNYFY2025 · Dec 31, 2025Shares Outstanding
606.64MSharesUpdated Sep 20, 2026Float Shares
398.39MSharesUpdated Sep 20, 2026% Held by Insiders
38.03%vs all stocks
% Held by Institutions
4.26%vs all stocks
Total Cash (MRQ)
3.10BCNY463.24M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.12CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.08BCNY161.03M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1318xvs Medical Devices peers
Current Ratio (MRQ)
1.42xvs Medical Devices peers
Book Value per Share (MRQ)
12.96CNYUpdated Sep 20, 2026Total Assets
14.82BCNY2.21B · vs all stocks (USD)
Total Current Assets
8.89BCNYFY2025 · Dec 31, 2025Total Liabilities
6.86BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.93BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
314.89MCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.55BCNYFY2025 · Dec 31, 2025Cash
2.97BCNYFY2025 · Dec 31, 2025Cash Equivalents
128.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.09BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.91BCNYFY2025 · Dec 31, 2025Inventory
2.90BCNYFY2025 · Dec 31, 2025Accounts Payable
2.53BCNYFY2025 · Dec 31, 2025Short-term Debt
1.05BCNYFY2025 · Dec 31, 2025Other Current Liabilities
355.53MCNYFY2025 · Dec 31, 2025Long-term Debt
139.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
606.68MCNYFY2025 · Dec 31, 2025Retained Earnings
4.11BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.96BCNY1.19B · vs all stocks (USD)
Treasury Stock
17.74MCNYFY2025 · Dec 31, 202552-Week Low
11.40CNYUpdated Sep 20, 202652-Week High
17.27CNYUpdated Sep 20, 202652-Week Change
-25.28%vs all stocks
Beta
0.1130xvs all stocks
50-Day MA
12.65CNYUpdated Sep 20, 2026200-Day MA
13.91CNYUpdated Sep 20, 2026Avg 10-Day Volume
3.73MSharesUpdated Sep 20, 2026Avg 30-Day Volume
5.47MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.7000CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 25.1%, lower than 95% of its Medical Devices peers (median 58.7%)Significant
Gross margin: 0.25Industry median: 0.59Industry P5: 0.26Peers compared: 60.00
P/E ratio is 17.4×, lower than 95% of its Medical Devices peers (median 27.26×)Notable
P/E ratio: 17.40Industry median: 27.26Industry P5: 17.84Peers compared: 60.00
Price-to-book is 0.94×, lower than 95% of its Medical Devices peers (median 2.9×)Notable
Price-to-book: 0.94Industry median: 2.90Industry P5: 1.18Peers compared: 60.00
Financial Health
Altman Z-Score 2.02: grey zoneSignificant
Altman Z-Score: 2.02
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $1.51B, above the global median of $548.88MNotable
Revenue (USD): 1,508,069,024.133Global Median: 548,883,780.48
Levered free cash flow is $46.19M, above the global median of $18.73MNotable
Levered free cash flow (USD): 46,191,521.341Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Artivion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Wandong Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sequent Scientific Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hob Biotech Group Suzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Resources Boya Bio-Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Yunnan Jianzhi Health Chain Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability
Hangzhou Huawang New Materials Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability
Shutterstock Inc.
1 interpretationClose Below 40W SMA With Profitability